{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:22:54Z","timestamp":1782177774145,"version":"3.54.5"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1097\/gme.0b013e318276c4ea","type":"journal-article","created":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T15:14:41Z","timestamp":1357658081000},"page":"496-503","source":"Crossref","is-referenced-by-count":9,"title":["Effects of short-term estradiol and norethindrone acetate treatment on the breasts of normal postmenopausal women"],"prefix":"10.1097","volume":"20","author":[{"given":"Guojun","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-\u00c5ke","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Wilczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt-Marie","family":"Landgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-5-20210211","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5694\/j.1326-5377.2009.tb02423.x","article-title":"The benefits of oestrogen following menopause: why hormone replacement therapy should be offered to postmenopausal women.","volume":"190","author":"Wren","year":"2009","journal-title":"Med J Aust"},{"key":"R4-5-20210211","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-137-10-200211190-00009","article-title":"Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials.","volume":"137","author":"Kronenberg","year":"2002","journal-title":"Ann Intern Med"},{"key":"R5-5-20210211","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.288.7.872","article-title":"Postmenopausal hormone replacement therapy: scientific review.","volume":"288","author":"Nelson","year":"2002","journal-title":"JAMA"},{"key":"R6-5-20210211","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1056\/NEJM197512042932302","article-title":"Association of exogenous estrogen and endometrial carcinoma.","volume":"293","author":"Smith","year":"1975","journal-title":"N Engl J Med"},{"key":"R7-5-20210211","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/PAP.0b013e31802ef00f","article-title":"Postmenopausal hormone replacement therapy: endometrial and breast effects.","volume":"14","author":"Yeh","year":"2007","journal-title":"Adv Anat Pathol"},{"key":"R8-5-20210211","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Womens Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R9-5-20210211","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Womens Health Initiative randomized trial.","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"key":"R10-5-20210211","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/jnci\/dji279","article-title":"Estrogen-plus-progestin use and mammographic density in postmenopausal women: Womens Health Initiative randomized trial.","volume":"97","author":"McTiernan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R11-5-20210211","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study.","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"R12-5-20210211","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.maturitas.2009.07.015","article-title":"The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence.","volume":"64","author":"Verkooijen","year":"2009","journal-title":"Maturitas"},{"key":"R13-5-20210211","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/13697130802474623","article-title":"Re-think HRT: behind the scene of perceptions.","volume":"11","author":"Pines","year":"2008","journal-title":"Climacteric"},{"key":"R14-5-20210211","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.maturitas.2008.10.009","article-title":"The EMAS 2008 update on clinical recommendations on postmenopausal hormone replacement therapy.","volume":"61","author":"Gompel","year":"2008","journal-title":"Maturitas"},{"key":"R16-5-20210211","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsbmb.2005.02.014","article-title":"Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.","volume":"96","author":"Campagnoli","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R17-5-20210211","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1677\/ERC-06-0060","article-title":"Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment.","volume":"14","author":"Biglia","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"R18-5-20210211","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1034\/j.1600-0412.2003.00551.x","article-title":"Hormone replacement therapy and risk of breast cancer: the role of progestins.","volume":"82","author":"Stahlberg","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R19-5-20210211","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.maturitas.2004.06.007","article-title":"Exogenous progestagens and the human breast.","volume":"49","author":"Sitruk-Ware","year":"2004","journal-title":"Maturitas"},{"key":"R21-5-20210211","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3109\/09513590903056878","article-title":"Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.","volume":"25","author":"Gadducci","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"R22-5-20210211","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/13697130310001651472","article-title":"A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolone and continuous combined estrogen-progestogen treatment.","volume":"7","author":"Conner","year":"2004","journal-title":"Climacteric"},{"key":"R23-5-20210211","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1022987618445","article-title":"Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology.","volume":"78","author":"Conner","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"R24-5-20210211","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/GME.0b013e31802cc7d0","article-title":"Isoflavone treatment for acute menopausal symptoms.","volume":"14","author":"Cheng","year":"2007","journal-title":"Menopause"},{"key":"R25-5-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5122(97)00063-7","article-title":"Psychosocial factors associated with the use of hormonal replacement therapy in a longitudinal follow-up of Swedish women.","volume":"28","author":"Collins","year":"1997","journal-title":"Maturitas"},{"key":"R26-5-20210211","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2214\/ajr.126.6.1130","article-title":"Breast patterns as an index of risk for developing breast cancer.","volume":"126","author":"Wolfe","year":"1976","journal-title":"AJR Am J Roentgenol"},{"key":"R27-5-20210211","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1470-2045(09)70262-1","article-title":"Ki67 in breast cancer: prognostic and predictive potential.","volume":"11","author":"Yerushalmi","year":"2010","journal-title":"Lancet Oncol"},{"key":"R28-5-20210211","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.maturitas.2008.07.007","article-title":"Could transdermal estradiol progesterone be a safer postmenopausal HRT A review.","volume":"60","author":"LHermite","year":"2008","journal-title":"Maturitas"},{"key":"R29-5-20210211","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1634\/theoncologist.2008-0230","article-title":"The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine.","volume":"14","author":"Ross","year":"2009","journal-title":"Oncologist"},{"key":"R30-5-20210211","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2neu oncogene.","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"R31-5-20210211","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0959-8049(01)00383-5","article-title":"Evaluation of oestrogen receptor wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers.","volume":"38","author":"Omoto","year":"2002","journal-title":"Eur J Cancer"},{"key":"R32-5-20210211","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/13697130802448387","article-title":"Expression of the androgen receptor and syndecan-1 in breast tissue during different hormonal treatments in cynomolgus monkeys.","volume":"12","author":"Hofling","year":"2009","journal-title":"Climacteric"},{"key":"R33-5-20210211","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mce.2010.06.010","article-title":"Relative progestational and androgenic activity of four progestins used for male hormonal contraception assessed in vitro in relation to their ability to suppress LH secretion in the castrate male rat.","volume":"328","author":"Attardi","year":"2010","journal-title":"Mol Cell Endocrinol"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00042192-201305000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T15:54:51Z","timestamp":1646236491000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-201305000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e318276c4ea","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}